Pharmaceutical News

RSS

Woodcock discusses FDA's ongoing initiative to reduce preventable harm from medication use

An article by Janet Woodcock, M.D., director of the FDA's Center for Drug Evaluation and Research, titled "A Difficult Balance - Pain Management, Drug Safety, and the FDA," appears in the Nov. 26, 2009 issue of The New England Journal of Medicine.

5 Jan 2010

HHS to host special flu webcast on Jan 6, 2010

The U.S. Department of Health and Human Services (HHS) will host a Know What to Do about the Flu Webcast on Wednesday, January 6, 2010 from 1 – 2 p.m. EST.

5 Jan 2010

January issue of Chest presents new studies on COPD

A new study shows that poor lung function during adolescence and through midlife may be influenced by several factors, including birth weight, height, and gender.

5 Jan 2010

St. John's wort not effective in treating IBS

A Mayo Clinic research study published in the January issue of the American Journal of Gastroenterology finds that St. John's wort is not an effective treatment for irritable bowel syndrome (IBS). While antidepressants are frequently used to treat IBS, to date, no study has examined the success of using the herbal supplement St. John's wort in treating IBS.

5 Jan 2010

Children’s vaccination coverage rises substantially in U.S.

About three-quarters of U.S. children received recommended vaccinations in 2008, up from about half in 2000, reports a new study from the Centers for Disease Control and Prevention (CDC).

5 Jan 2010

Citicoline supplements may reduce cravings and increase satiety

The obesity crisis in the United States has now grown to epidemic proportion. And as the list of consequential health conditions and diseases continues to expand as well, there are major movements toward helping Americans lose weight.

5 Jan 2010

Vienna scientists develop new technique for producing H1N1 vaccines

Scientists in Vienna have developed a new technique for producing vaccines for H1N1, 'swine flu', based on insect cells. The research, published today in the Biotechnology Journal, reveals how influenza vaccines can be produced faster than through the traditional method of egg-based production, revealing a new strategy for the fight against influenza pandemics.

5 Jan 2010

Study shows increasing number of U.S. adults are taking antidepressants and antipsychotic medications

An increasing number of U.S. adults are being prescribed combinations of antidepressants and antipsychotic medications, according to a report in the January issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

5 Jan 2010

CDC leaders to team up with USOC to hold H1N1 vaccination events in Alaska and Colorado

As America gears up for the 2010 Olympic and Paralympic Winter Games, the U.S. Surgeon General and Centers for Disease Control and Prevention (CDC) leaders will team up with the United States Olympic Committee (USOC) to hold H1N1 vaccination events at the Olympic Training Center in Colorado Springs, Colorado, and the 2010 U.S. Cross Country Championships in Anchorage, Alaska on Tuesday, January 5, 2010.

5 Jan 2010

Further stay of Cipher's NDA for CIP-TRAMADOL ER terminated

Cipher Pharmaceuticals Inc. today announced a final judgment (the "Cipher Judgment") has been entered in favour of Cipher in relation to pending patent litigation with Purdue Pharma Products L.P. and Napp Pharmaceutical Group Ltd. (together "Purdue") in the United States District Court for the Eastern District of Virginia (the "Court").

5 Jan 2010

Coformulation of rilpivirine and Truvada HIV drugs will achieve sales of more than $2 billion in 2018

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in 2018, the fixed dose coformulation of Tibotec's rilpivirine and Gilead's Truvada will achieve blockbuster sales of more than $2 billion in the HIV drug market in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

5 Jan 2010

Stop & Shop to hold H1N1 vaccination clinics at select pharmacies

The Stop & Shop Supermarket Company Giant today announced it will hold H1N1 vaccination clinics at select pharmacies starting January 8, 2010. Immunizations will cost $15 and be administered as long as quantities associated with this program are available.

5 Jan 2010

Department of Health urges Pennsylvanians to get vaccinated against H1N1 flu

All Pennsylvanians are urged to take advantage of the increasing supply of H1N1 vaccine by getting immunized at the upcoming vaccination clinics being offered by the Department of Health.

5 Jan 2010

Anti-inflammatory prescription drug reduces the risk of common skin cancer in humans

A widely-available anti-inflammatory prescription drug can reduce the risk of a common skin cancer in humans, according to a researcher at Stanford's School of Medicine.

5 Jan 2010

Cornell study shows we pour too little or too much medicine, depending on spoon size

A new study published in the Jan. 5 issue of the Annals of Internal Medicine illustrates the dangers of using kitchen spoons to measure liquid medicine.

5 Jan 2010

Use of botulinum type A toxins may offer cost efficient alternative to serotonin reuptake inhibitors

According to an article in the January 2010 edition of Drugs In Dermatology (abstract available at http://jddonline.com ), the use of botulinum type A toxins such as Botox and Dysport may offer a cost efficient alternative to the use of selective serotonin reuptake inhibitors.

5 Jan 2010

Majority of Medicaid patients on antipsychotic drugs do not undergo metabolic tests, says study

Despite government warnings and professional recommendations about diabetes risks associated with second-generation antipsychotic drugs, fewer than one-third of Medicaid patients who are treated with these medications undergo tests of blood glucose or lipid levels, according to a report in the January issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

5 Jan 2010

VELCADE sNDA receives FDA approval

Millennium: The Takeda Oncology Company today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for VELCADE, which expands the label to include long-term (median follow-up 36.7 months) overall survival (OS) data from the landmark VISTA trial and provides specific dosing recommendations for patients with hepatic impairment. The VISTA trial examined the use of VELCADE based therapy in patients with previously untreated multiple myeloma (MM).

5 Jan 2010

H1N1 vaccine available at Walgreens pharmacies and Take Care Clinics

Every Walgreens pharmacy, every day. The once-scarce H1N1 vaccine is now available daily at all of the more than 7,100 Walgreens pharmacies and 350 Take Care Clinics throughout the country.

5 Jan 2010

AP series examines worldwide impact of drug resistance

The Associated Press reports on how the misuse of drugs worldwide has contributed to drug-resistant diseases in a series of articles following a six-month investigation by the news service.

5 Jan 2010

Pharmaceutical News

Woodcock discusses FDA's ongoing initiative to reduce preventable harm from medication use

HHS to host special flu webcast on Jan 6, 2010

January issue of Chest presents new studies on COPD

St. John's wort not effective in treating IBS

Children’s vaccination coverage rises substantially in U.S.

Citicoline supplements may reduce cravings and increase satiety

Vienna scientists develop new technique for producing H1N1 vaccines

Study shows increasing number of U.S. adults are taking antidepressants and antipsychotic medications

CDC leaders to team up with USOC to hold H1N1 vaccination events in Alaska and Colorado

Further stay of Cipher's NDA for CIP-TRAMADOL ER terminated

Coformulation of rilpivirine and Truvada HIV drugs will achieve sales of more than $2 billion in 2018

Stop & Shop to hold H1N1 vaccination clinics at select pharmacies

Department of Health urges Pennsylvanians to get vaccinated against H1N1 flu

Anti-inflammatory prescription drug reduces the risk of common skin cancer in humans

Cornell study shows we pour too little or too much medicine, depending on spoon size

Use of botulinum type A toxins may offer cost efficient alternative to serotonin reuptake inhibitors

Majority of Medicaid patients on antipsychotic drugs do not undergo metabolic tests, says study

VELCADE sNDA receives FDA approval

H1N1 vaccine available at Walgreens pharmacies and Take Care Clinics

AP series examines worldwide impact of drug resistance

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News